Today: 15 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Oracle Stock Slides as OpenAI Misses Put $300 Billion AI Deal Under Pressure

Oracle Stock Slides as OpenAI Misses Put $300 Billion AI Deal Under Pressure

Oracle shares fell 7.7% to $159.80 in premarket trading Tuesday after reports OpenAI missed recent user and revenue targets. CoreWeave dropped 7.4%, and SoftBank closed down nearly 10% in Tokyo. Oracle has a $300 billion, five-year contract to supply computing power to OpenAI. Lenders remain cautious, with Oracle expected to need over $100 billion in additional cash funding for 2027 and early 2028.
UPS Earnings Beat Wall Street, But Amazon Pullback Is the Real Test

UPS Earnings Beat Wall Street, But Amazon Pullback Is the Real Test

UPS reported first-quarter revenue of $21.2 billion and adjusted earnings of $1.07 per share, beating analyst estimates. Adjusted profit fell 28% from a year earlier, and shares dropped 3% in premarket trading. Domestic revenue declined 2.3% to $14.13 billion on lower volume, while international revenue rose 3.8% to $4.54 billion. UPS kept its 2026 financial targets and dividend plans unchanged.
Oil Crisis Just Changed Fossil Fuels Forever, IEA Chief Warns as Brent Tops $110

Oil Crisis Just Changed Fossil Fuels Forever, IEA Chief Warns as Brent Tops $110

Brent crude rose to $111.22 a barrel Tuesday as disruption in the Strait of Hormuz continued after stalled U.S.-Iran talks. IEA chief Fatih Birol warned the crisis has permanently damaged trust in fossil fuels and poses major risks to global energy security. Asia’s crude imports are set to fall 22% in April, hitting a 10-year low. The IEA expects global oil demand to contract by 80,000 barrels per day this year.
28 April 2026
US Stock Market Today: Futures Slip as $110 Oil and AI Jitters Test Wall Street’s Record Run

US Stock Market Today: Futures Slip as $110 Oil and AI Jitters Test Wall Street’s Record Run

Nasdaq 100 futures fell 0.7% and S&P 500 futures dropped 0.3% early Tuesday, pressured by rising oil prices and renewed concerns over AI stocks. Brent crude climbed to $111.20 a barrel after U.S. officials rejected Iran’s proposal on its nuclear program. Oracle fell 4.6% pre-market after reports OpenAI missed internal targets. UPS dropped 3% after reporting a 28% profit decline.
US Stock Market Today: S&P 500, Nasdaq Hit Records as After-Hours Trading Edges Higher

US Stock Market Today: S&P 500, Nasdaq Hit Records as After-Hours Trading Edges Higher

The S&P 500 and Nasdaq closed at record highs Monday, while the Dow slipped 62.67 points to 49,168.04. After-hours, major U.S. indexes edged up less than 0.2%. Nvidia jumped 4% to a new high, topping $5 trillion in value, while Domino’s Pizza fell after forecasting weaker 2026 growth. Investors await Big Tech earnings and a Federal Reserve decision this week.
Youxin Technology Stock Jumps After $10.8 Million TikTok Partner Deal: What Is Behind the Move

Youxin Technology Stock Jumps After $10.8 Million TikTok Partner Deal: What Is Behind the Move

Youxin shares jumped 149.62% to $2.32 Monday after the company agreed to buy 18% of YATOP, a TikTok-focused commerce partner, for $10.8 million in stock. The deal, disclosed in a U.S. SEC filing, implies a $60.8 million equity value for YATOP and is expected to close in May 2026. YATOP reported $6.5 million in 2025 revenue and $2 million net profit.
Gold Price Today: The $4,700 Rally Faces Its First Big Fed Test

Gold Price Today: The $4,700 Rally Faces Its First Big Fed Test

Gold dropped below $4,700 an ounce Monday, with spot prices down 0.6% at $4,682.13 and June futures settling at $4,693.70. Uncertainty over the U.S.-Israeli war on Iran and the Fed’s rate outlook weighed on the market. Analysts raised their 2026 gold forecast to a record $4,916, but technical signals pointed to fading momentum. Silver, platinum, and palladium also declined.
28 April 2026
Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

Rambus shares fell 10.8% to $141.31 Monday after reporting first-quarter revenue of $180.2 million and net income of $59.9 million. Product revenue rose 15% to $88 million, driven by AI data-center demand. The company forecast higher second-quarter product revenue but said results depend on customer deals. Rambus recently launched a new server memory module aimed at AI systems.
Edesa Biotech Stock Soars 54%: What’s Driving the ARDS Drug Rally Now

Edesa Biotech Stock Soars 54%: What’s Driving the ARDS Drug Rally Now

Edesa Biotech shares surged 53.9% to $11.17 on Nasdaq Monday, with trading volume near 9 million shares. The spike follows renewed focus on February data showing paridiprubart cut 28-day mortality in ARDS patients to 24% from 33%. CEO Par Nijhawan and principal investigator Ted Steiner are set to present at May ATS meetings. Edesa ended last quarter with $12.1 million in cash and a $68.2 million deficit.
Why Celestica Stock Fell After Strong Earnings and a Bigger AI Forecast

Why Celestica Stock Fell After Strong Earnings and a Bigger AI Forecast

Celestica raised its 2026 revenue forecast to $19 billion and adjusted EPS target to $10.15 after reporting Q1 revenue of $4.05 billion, up 53%. Shares fell in after-hours trading despite beating profit expectations, following a 50% gain in April. The company’s CCS unit saw revenue jump 76% to $3.24 billion. Celestica also announced a new 1.6-terabit switch program set to ramp in 2027.
McDonald’s (MCD) Stock Drops as Netflix Happy Meal Push Runs Into a Tougher Fast-Food Market

McDonald’s (MCD) Stock Drops as Netflix Happy Meal Push Runs Into a Tougher Fast-Food Market

McDonald’s shares dropped nearly 3% Monday after Erste Group downgraded the stock to Hold, citing slower profit growth. The move comes as McDonald’s prepares to launch a “Stranger Things” Happy Meal promotion with Netflix on May 5. The stock traded at $291.08, down $8.28. McDonald’s has also introduced new value meals amid rising competition and consumer price sensitivity.
27 April 2026
Critical Metals Corp Stock Rallies as $835 Million European Lithium Deal Targets Full Greenland Rare Earth Control

Critical Metals Corp Stock Rallies as $835 Million European Lithium Deal Targets Full Greenland Rare Earth Control

Critical Metals Corp. agreed to buy European Lithium Ltd. for about $835 million, seeking full control of Greenland’s Tanbreez rare earth project. The deal would give Critical Metals all of Tanbreez, one of the world’s largest rare earth deposits, and add $219 million in cash. Shares of Critical Metals jumped to $13.85 in late Nasdaq trading. The move comes as the U.S. and EU deepen cooperation on critical minerals.
1 53 54 55 56 57 812

Stock Market Today

  • Illumina (ILMN) Shares Appear Undervalued After 77% Annual Gain, DCF Model Shows
    May 15, 2026, 1:49 AM EDT. Illumina's stock gained 77.1% over the past year, yet a Discounted Cash Flow (DCF) analysis estimates its intrinsic value at $170.93 per share, about 16.2% above the current price of $143.24. The DCF approach, which forecasts future free cash flows discounted to present value, suggests that despite recent rally, Illumina remains undervalued. Short term gains have contrasted with longer term declines, as the shares dropped 26.8% and 62.8% over three and five years, respectively. Simply Wall St assigns Illumina a valuation score of 3 out of 6, reflecting mixed assessments of its fair price. Investors watching life sciences and genomics sectors may find the stock's current pricing offers a potential entry point given its expected earnings growth over the coming decade.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 15.05.2026

15 May 2026
LIVEMarkets rolling coverageStarted: May 15, 2026, 12:00 AM EDTUpdated: May 15, 2026, 1:51 AM EDT Illumina (ILMN) Shares Appear Undervalued After 77% Annual Gain, DCF Model Shows May 15, 2026, 1:49 AM EDT. Illumina's stock gained 77.1% over the past year, yet a Discounted Cash Flow (DCF) analysis estimates its intrinsic value at $170.93 per share, about 16.2% above the current price of $143.24. The DCF approach, which forecasts future free cash flows discounted to present value, suggests that despite recent rally, Illumina remains undervalued. Short term gains have contrasted with longer term declines, as the shares dropped 26.8% and
US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Go toTop